{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:23:18Z","timestamp":1792002198410,"version":"4.4.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2012,8,28]],"date-time":"2012-08-28T00:00:00Z","timestamp":1346112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,8,28]],"date-time":"2012-08-28T00:00:00Z","timestamp":1346112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1038\/mp.2012.125","type":"journal-article","created":{"date-parts":[[2012,8,28]],"date-time":"2012-08-28T06:26:34Z","timestamp":1346135194000},"page":"1119-1124","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":186,"title":["Pro-inflammatory cytokines as predictors of antidepressant effects of exercise in major depressive disorder"],"prefix":"10.1038","volume":"18","author":[{"given":"C D","family":"Rethorst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M S","family":"Toups","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T L","family":"Greer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P A","family":"Nakonezny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T J","family":"Carmody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B D","family":"Grannemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R M","family":"Huebinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R C","family":"Barber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M H","family":"Trivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,8,28]]},"reference":[{"key":"BFmp2012125_CR1","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","volume":"163","author":"M Trivedi","year":"2006","unstructured":"Trivedi M, Rush A, Wisniewski S, Nierenberg A, Warden D, Ritz L et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR* D: implications for clinical practice. Am J Psychiatry 2006; 163: 28.","journal-title":"Am J Psychiatry"},{"key":"BFmp2012125_CR2","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","volume":"163","author":"A Rush","year":"2006","unstructured":"Rush A, Trivedi M, Wisniewski S, Nierenberg A, Stewart J, Warden D et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR* D report. Am J Psychiatry 2006; 163: 1905.","journal-title":"Am J Psychiatry"},{"key":"BFmp2012125_CR3","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1056\/NEJMoa052963","volume":"354","author":"A Rush","year":"2006","unstructured":"Rush A, Trivedi M, Wisniewski S, Stewart J, Nierenberg A, Thase M et al. Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. N Engl J Med 2006; 354: 1231.","journal-title":"N Engl J Med"},{"key":"BFmp2012125_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.amepre.2004.09.003","volume":"28","author":"AL Dunn","year":"2005","unstructured":"Dunn AL, Trivedi MH, Kampert JB, Clark CG, Chambliss HO . Exercise treatment for depression. Am J Prev Med 2005; 28: 1\u20138.","journal-title":"Am J Prev Med"},{"key":"BFmp2012125_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2165\/00007256-200939060-00004","volume":"39","author":"CD Rethorst","year":"2009","unstructured":"Rethorst CD, Wipfli BM, Landers DM . The antidepressive effects of exercise: a meta-analysis of randomized trials. Sport Med 2009; 39: 21.","journal-title":"Sport Med"},{"key":"BFmp2012125_CR6","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1097\/PSY.0b013e318148c19a","volume":"69","author":"JA Blumenthal","year":"2007","unstructured":"Blumenthal JA, Babyak MA, Doraiswamy PM, Watkins L, Hoffman BM, Barbour KA et al. Exercise and pharmacotherapy in the treatment of major depressive disorder. Psychosom Med 2007; 69: 587\u2013596.","journal-title":"Psychosom Med"},{"key":"BFmp2012125_CR7","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1192\/bjp.180.5.411","volume":"180","author":"AS Mather","year":"2002","unstructured":"Mather AS, Rodriguez C, Guthrie MF, McHarg AM, Reid IC, McMurdo ME . Effects of exercise on depressive symptoms in older adults with poorly responsive depressive disorder: randomised controlled trial. Br J Psychiatry 2002; 180: 411.","journal-title":"Br J Psychiatry"},{"key":"BFmp2012125_CR8","doi-asserted-by":"publisher","first-page":"677","DOI":"10.4088\/JCP.10m06743","volume":"72","author":"MH Trivedi","year":"2011","unstructured":"Trivedi MH, Greer TL, Church TS, Carmody TJ, Grannemann BD, Galper DI et al. Exercise as an augmentation treatment for nonremitted major depressive disorder: a randomized, parallel dose comparison. J Clin Psychiatry 2011; 72: 677.","journal-title":"J Clin Psychiatry"},{"key":"BFmp2012125_CR9","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/j.jpsychires.2011.05.002","volume":"45","author":"MS Toups","year":"2011","unstructured":"Toups MS, Greer TL, Kurian BT, Grannemann BD, Carmody TJ, Huebinger R et al. Effects of serum brain derived neurotrophic factor on exercise augmentation treatment of depression. J Psychiatr Res 2011; 45: 1301\u20131306.","journal-title":"J Psychiatr Res"},{"key":"BFmp2012125_CR10","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1249\/MSS.0b013e3181de7d51","volume":"42","author":"CD Rethorst","year":"2010","unstructured":"Rethorst CD, Landers DM, Nagoshi CT, Ross JT . Efficacy of exercise in reducing depressive symptoms across 5-HTTLPR genotypes. Med Sci Sports Exerc 2010; 42: 2141\u20132147.","journal-title":"Med Sci Sports Exerc"},{"key":"BFmp2012125_CR11","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","volume":"67","author":"Y Dowlati","year":"2010","unstructured":"Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK et al. A meta-analysis of cytokines in major depression. Biol Psychiatry 2010; 67: 446\u2013457.","journal-title":"Biol Psychiatry"},{"key":"BFmp2012125_CR12","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.pnpbp.2007.09.015","volume":"32","author":"T Eller","year":"2008","unstructured":"Eller T, Vasar V, Shlik J, Maron E . Pro-inflammatory cytokines and treatment response to escitalopram in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32: 445\u2013450.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BFmp2012125_CR13","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.4088\/JCP.v67n1114","volume":"67","author":"R Leo","year":"2006","unstructured":"Leo R, Di Lorenzo G, Tesauro M, Razzini C, Forleo GB, Chiricolo G et al. Association between enhanced soluble CD40 ligand and proinflammatory and prothrombotic states in major depressive disorder: pilot observations on the effects of selective serotonin reuptake inhibitor therapy. J Clin Psychiatry 2006; 67: 1760\u20131766.","journal-title":"J Clin Psychiatry"},{"key":"BFmp2012125_CR14","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1159\/000054867","volume":"43","author":"A Kagaya","year":"2001","unstructured":"Kagaya A, Kugaya A, Takebayashi M, Fukue-Saeki M, Saeki T, Yamawaki S et al. Plasma concentrations of interleukin-1beta, interleukin-6, soluble interleukin-2 receptor and tumor necrosis factor alpha of depressed patients in Japan. Neuropsychobiology 2001; 43: 59.","journal-title":"Neuropsychobiology"},{"key":"BFmp2012125_CR15","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/hup.717","volume":"20","author":"AD Basterzi","year":"2005","unstructured":"Basterzi AD, Aydemir C, Kisa C, Aksaray S, Tuzer V, Yazici K et al. IL-6 levels decrease with SSRI treatment in patients with major depression. Hum Psychopharmacol 2005; 20: 473\u2013476.","journal-title":"Hum Psychopharmacol"},{"key":"BFmp2012125_CR16","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.pnpbp.2009.03.020","volume":"33","author":"R Yoshimura","year":"2009","unstructured":"Yoshimura R, Hori H, Ikenouchi-Sugita A, Umene-Nakano W, Ueda N, Nakamura J . Higher plasma interleukin-6 (IL-6) level is associated with SSRI- or SNRI-refractory depression. Prog Neuropsychopharmacol Biol Psychiatry 2009; 33: 722\u2013726.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BFmp2012125_CR17","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s00213-003-1566-z","volume":"170","author":"C Tuglu","year":"2003","unstructured":"Tuglu C, Kara SH, Caliyurt O, Vardar E, Abay E . Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder. Psychopharmacology (Berl) 2003; 170: 429\u2013433.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFmp2012125_CR18","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/S0893-133X(99)00134-7","volume":"22","author":"S Lanquillon","year":"2000","unstructured":"Lanquillon S, Krieg JC, Bening-Abu-Shach U, Vedder H . Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology 2000; 22: 370\u2013379.","journal-title":"Neuropsychopharmacology"},{"key":"BFmp2012125_CR19","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.bbi.2005.12.002","volume":"20","author":"M Kohut","year":"2006","unstructured":"Kohut M, McCann D, Russell D, Konopka D, Cunnick J, Franke W et al. Aerobic exercise, but not flexibility\/resistance exercise, reduces serum IL-18, CRP, and IL-6 independent of beta-blockers, BMI, and psychosocial factors in older adults. Brain Behav Immun 2006; 20: 201.","journal-title":"Brain Behav Immun"},{"key":"BFmp2012125_CR20","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ijcard.2004.08.073","volume":"100","author":"E Goldhammer","year":"2005","unstructured":"Goldhammer E, Tanchilevitch A, Maor I, Beniamini Y, Rosenschein U, Sagiv M . Exercise training modulates cytokines activity in coronary heart disease patients. Int J Cardiol 2005; 100: 93.","journal-title":"Int J Cardiol"},{"key":"BFmp2012125_CR21","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1001\/jama.281.18.1722","volume":"281","author":"J Smith","year":"1999","unstructured":"Smith J, Dykes R, Douglas J, Krishnaswamy G, Berk S . Long-term exercise and atherogenic activity of blood mononuclear cells in persons at risk of developing ischemic heart disease. JAMA 1999; 281: 1722.","journal-title":"JAMA"},{"key":"BFmp2012125_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.amepre.2004.09.003","volume":"28","author":"AL Dunn","year":"2005","unstructured":"Dunn AL, Trivedi MH, Kampert JB, Clark CG, Chambliss HO . Exercise treatment for depression: efficacy and dose response. Am J Prev Med 2005; 28: 1\u20138.","journal-title":"Am J Prev Med"},{"key":"BFmp2012125_CR23","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1191\/1740774506cn151oa","volume":"3","author":"MH Trivedi","year":"2006","unstructured":"Trivedi MH, Greer TL, Grannemann BD, Church TS, Galper DI, Sunderajan P et al. TREAD: TReatment with Exercise Augmentation for Depression: study rationale and design. Clin Trials 2006; 3: 291.","journal-title":"Clin Trials"},{"key":"BFmp2012125_CR24","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1161\/CIRCULATIONAHA.107.185649","volume":"116","author":"WL Haskell","year":"2007","unstructured":"Haskell WL, Lee IM, Pate RR, Powell KE, Blair SN, Franklin BA et al. Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Circulation 2007; 116: 1081\u20131093.","journal-title":"Circulation"},{"key":"BFmp2012125_CR25","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1001\/jama.1995.03520290054029","volume":"273","author":"RR Pate","year":"1995","unstructured":"Pate RR, Pratt M, Blair SN, Haskell WL, Macera CA, Bouchard C et al. Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA 1995; 273: 402\u2013407.","journal-title":"JAMA"},{"key":"BFmp2012125_CR26","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/mpr.79","volume":"9","author":"AJ Rush","year":"2000","unstructured":"Rush AJ, Carmody TJ, Reimitz PE . The inventory of depressive symptomatology (IDS): clinician (IDS C) and self report (IDS SR) ratings of depressive symptoms. Int J Methods Psychiatr Res 2000; 9: 45\u201359.","journal-title":"Int J Methods Psychiatr Res"},{"key":"BFmp2012125_CR27","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S0006-3223(02)01866-8","volume":"54","author":"AJ Rush","year":"2003","unstructured":"Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN et al. The 16-item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry 2003; 54: 573\u2013583.","journal-title":"Biol Psychiatry"},{"key":"BFmp2012125_CR28","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1017\/S0033291703001107","volume":"34","author":"MH Trivedi","year":"2004","unstructured":"Trivedi MH, Rush AJ, Ibrahim HM, Carmody TJ, Biggs MM, Suppes T et al. The inventory of depressive symptomatology, clinician rating (IDS-C) and self-report (IDS-SR), and the quick inventory of depressive symptomatology, clinician rating (QIDS-C) and self-report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation. Psychol Med 2004; 34: 73\u201382.","journal-title":"Psychol Med"},{"key":"BFmp2012125_CR29","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"M Hamilton","year":"1960","unstructured":"Hamilton M . A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BFmp2012125_CR30","doi-asserted-by":"publisher","first-page":"983","DOI":"10.2307\/2533558","volume":"53","author":"MG Kenward","year":"1997","unstructured":"Kenward MG, Roger JH . Small sample inference for fixed effects from restricted maximum likelihood. Biometrics 1997; 53: 983\u2013997.","journal-title":"Biometrics"},{"key":"BFmp2012125_CR31","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/mp.2010.117","volume":"17","author":"LC Lazzeroni","year":"2012","unstructured":"Lazzeroni LC, Ray A . The cost of large numbers of hypothesis tests on power, effect size and sample size. Mol Psychiatry 2012; 17: 108\u2013114.","journal-title":"Mol Psychiatry"},{"key":"BFmp2012125_CR32","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/S0895-4356(00)00314-0","volume":"54","author":"R Bender","year":"2001","unstructured":"Bender R, Lange S . Adjusting for multiple testing\u2013when and how? J Clin Epidemiol 2001; 54: 343\u2013349.","journal-title":"J Clin Epidemiol"},{"key":"BFmp2012125_CR33","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/00001648-199001000-00010","volume":"1","author":"KJ Rothman","year":"1990","unstructured":"Rothman KJ . No adjustments are needed for multiple comparisons. Epidemiology 1990; 1: 43\u201346.","journal-title":"Epidemiology"},{"key":"BFmp2012125_CR34","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1038\/npp.2011.132","volume":"36","author":"J Hannestad","year":"2011","unstructured":"Hannestad J, DellaGioia N, Bloch M . The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology 2011; 36: 2452\u20132459.","journal-title":"Neuropsychopharmacology"},{"key":"BFmp2012125_CR35","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1055\/s-0029-1202263","volume":"42","author":"C Song","year":"2009","unstructured":"Song C, Halbreich U, Han C, Leonard B, Luo H . Imbalance between pro-and anti-inflammatory cytokines, and between Th1 and Th2 cytokines in depressed patients: the effect of electroacupuncture or fluoxetine treatment. Pharmacopsychiatry 2009; 42: 182.","journal-title":"Pharmacopsychiatry"},{"key":"BFmp2012125_CR36","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/npp.2011.277","volume":"37","author":"PA Zunszain","year":"2012","unstructured":"Zunszain PA, Anacker C, Cattaneo A, Choudhury S, Musaelyan K, Myint AM et al. Interleukin-1beta: a new regulator of the kynurenine pathway affecting human hippocampal neurogenesis. Neuropsychopharmacology 2012; 37: 939\u2013949.","journal-title":"Neuropsychopharmacology"},{"key":"BFmp2012125_CR37","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1056\/NEJMoa052964","volume":"354","author":"MH Trivedi","year":"2006","unstructured":"Trivedi MH, Fava M, Wisniewski SR, Thase ME, Quitkin F, Warden D et al. STAR*D study team. Medication augmentation after the failure of SSRIs for depression. N Engl J Med 2006; 354: 1243\u20131252.","journal-title":"N Engl J Med"},{"key":"BFmp2012125_CR38","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1159\/000332050","volume":"81","author":"M Fava","year":"2012","unstructured":"Fava M, Mischoulon D, Iosifescu D, Witte J, Pencina M, Flynn M et al. A double-blind, placebo-controlled study of aripiprazole adjunctive to antidepressant therapy among depressed outpatients with inadequate response to prior antidepressant therapy (ADAPT-A Study). Psychother Psychosom 2012; 81: 87\u201397.","journal-title":"Psychother Psychosom"},{"key":"BFmp2012125_CR39","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.biopsych.2008.11.029","volume":"65","author":"AH Miller","year":"2009","unstructured":"Miller AH, Maletic V, Raison CL . Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 2009; 65: 732\u2013741.","journal-title":"Biol Psychiatry"},{"key":"BFmp2012125_CR40","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/mp.2009.116","volume":"15","author":"CL Raison","year":"2010","unstructured":"Raison CL, Dantzer R, Kelley KW, Lawson MA, Woolwine BJ, Vogt G et al. CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression. Mol Psychiatry 2010; 15: 393\u2013403.","journal-title":"Mol Psychiatry"},{"key":"BFmp2012125_CR41","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.pnpbp.2010.04.011","volume":"35","author":"PA Zunszain","year":"2011","unstructured":"Zunszain PA, Anacker C, Cattaneo A, Carvalho LA, Pariante CM . Glucocorticoids cytokines and brain abnormalities in depression. Prog Neuropsychopharmacol Biol Psychiatry 2011; 35: 722\u2013729.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BFmp2012125_CR42","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2174\/1745017901006010115","volume":"6","author":"I Helmich","year":"2010","unstructured":"Helmich I, Latini A, Sigwalt A, Carta MG, Machado S, Velasques B et al. Neurobiological alterations induced by exercise and their impact on depressive disorders [corrected]. Clin Pract Epidemiol Ment Health 2010; 6: 115\u2013125.","journal-title":"Clin Pract Epidemiol Ment Health"},{"key":"BFmp2012125_CR43","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.1161\/01.CIR.0000132467.45278.59","volume":"109","author":"P Ridker","year":"2004","unstructured":"Ridker P, Wilson P, Grundy S . Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation 2004; 109: 2818.","journal-title":"Circulation"},{"key":"BFmp2012125_CR44","doi-asserted-by":"publisher","first-page":"441","DOI":"10.2217\/npy.11.49","volume":"1","author":"MS Toups","year":"2011","unstructured":"Toups MS, Trivedi MH . The role of metabolic dysfunction in treatment resistance of major depressive disorder. Neuropsychiatry 2011; 1: 441\u2013455.","journal-title":"Neuropsychiatry"},{"key":"BFmp2012125_CR45","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1007\/s12170-010-0106-8","volume":"4","author":"BJ Nicklas","year":"2010","unstructured":"Nicklas BJ, Beavers KM . Exercise, weight loss, and effects on inflammation. Current Cardiovascular Risk Reports 2010; 4: 284\u2013292.","journal-title":"Current Cardiovascular Risk Reports"},{"key":"BFmp2012125_CR46","doi-asserted-by":"publisher","first-page":"321","DOI":"10.2165\/00007256-199724050-00004","volume":"24","author":"JL Ivy","year":"1997","unstructured":"Ivy JL . Role of exercise training in the prevention and treatment of insulin resistance and non-insulin-dependent diabetes mellitus. Sport Med 1997; 24: 321\u2013336.","journal-title":"Sport Med"},{"key":"BFmp2012125_CR47","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/oby.2004.95","volume":"12","author":"R Ross","year":"2004","unstructured":"Ross R, Janssen I, Dawson J, Kungl AM, Kuk JL, Wong SL et al. Exercise-induced reduction in obesity and insulin resistance in women: a randomized controlled trial. Obes Res 2004; 12: 789\u2013798.","journal-title":"Obes Res"},{"key":"BFmp2012125_CR48","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.atherosclerosis.2009.05.009","volume":"207","author":"BJ Arsenault","year":"2009","unstructured":"Arsenault BJ, C\u00d9t\u00c8 M, Cartier A, Lemieux I, Despr\u00c8s JP, Ross R et al. Effect of exercise training on cardiometabolic risk markers among sedentary, but metabolically healthy overweight or obese postmenopausal women with elevated blood pressure. Atherosclerosis 2009; 207: 530.","journal-title":"Atherosclerosis"},{"key":"BFmp2012125_CR49","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1001\/jama.297.19.2081","volume":"297","author":"TS Church","year":"2007","unstructured":"Church TS, Earnest CP, Skinner JS, Blair SN . Effects of different doses of physical activity on cardiorespiratory fitness among sedentary, overweight or obese postmenopausal women with elevated blood pressure. JAMA 2007; 297: 2081.","journal-title":"JAMA"},{"key":"BFmp2012125_CR50","doi-asserted-by":"publisher","first-page":"e4515","DOI":"10.1371\/journal.pone.0004515","volume":"4","author":"TS Church","year":"2009","unstructured":"Church TS, Martin CK, Thompson AM, Earnest CP, Mikus CR, Blair SN . Changes in weight, waist circumference and compensatory responses with different doses of exercise among sedentary, overweight postmenopausal women. PLoS One 2009; 4: e4515.","journal-title":"PLoS One"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/mp2012125.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/mp2012125","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/mp2012125.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T23:11:59Z","timestamp":1648768319000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/mp2012125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,28]]},"references-count":50,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["BFmp2012125"],"URL":"https:\/\/doi.org\/10.1038\/mp.2012.125","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717956647.793461315","asserted-by":"object"}]},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,28]]},"assertion":[{"value":"6 March 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"TLG has received research funding from NARSAD. TJC has received a consulting fee from Cyberonics. MHT has received research support from the Agency for Healthcare Research and Quality (AHRQ), Corcept Therapeutics, Cyberonics, Merck, National Alliance for Research in Schizophrenia and Depression, National Institute of Mental Health, National Institute on Drug Abuse, Naurex, Novartis, Pharmacia and Upjohn, Predix Pharmaceuticals (Epix), Solvay Pharmaceuticals, Targacept and Valient. He has received consulting and speaker fees from Abbott Laboratories, Abdi Ibrahim, Akzo (Organon Pharmaceuticals), Alkermes, AstraZeneca, Axon Advisors, Bristol-Myers Squibb Company, Cephalon, Evotec, Fabre Kramer Pharmaceuticals, Forest Pharmaceuticals, GlaxoSmithKline, Janssen Pharmaceutica Products, Johnson and Johnson PRD, Libby, LP, Eli Lilly and Company, Lundbeck, Meade Johnson, MedAvante, Medtronic, Neuronetics, Otsuka Pharmaceuticals, Pamlab, Parke-Davis Pharmaceuticals, Pfizer, PgxHealth, Rexahn Pharmaceuticals, Sepracor, SHIRE Development, Sierra, Takeda,Tal Medical\/Puretech, Transcept, VantagePoint and Wyeth-Ayerst Laboratories. The remaining authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}